QuantuMDx Group Ltd.
Point-of-care assays support personalized medicine
This article was originally published in Start Up
QuantuMDx Group Ltd. is developing handheld and portable low-cost diagnostic, genomic sequencing, and proteomic platforms that it thinks will promote the practice of personalized medicine in both developed and developing countries. The company aims to create devices that can provide results within minutes at point-of-care without the need for complex sample preparation processes, and that can integrate with mobile apps for ongoing patient support and education.